Overview

A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic Gastroenteritis

Status:
Not yet recruiting

Trial end date:
2026-05-27

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and efficacy of CC-93538 in adult and adolescent participants with eosinophilic gastroenteritis.

Phase:

Phase 3

Details

Lead Sponsor:

Celgene